


To provide a portfolio designed to achieve high and rising income by investing globally, primarily in equities in any economic sector whilst participating in long term capital growth.
| Name | % Net Assets | 
|---|---|
| Altria | 3.0% | 
| Pfizer | 3.0% | 
| Royal Dutch Shell | 2.8% | 
| Bristol-Myers Squibb | 2.7% | 
| McDonalds | 2.6% | 
| Coca-Cola | 2.5% | 
| Merck & Co | 2.5% | 
| Muenchener Rueckversicherungs | 2.5% | 
| Unilever | 2.4% | 
| Koninklijke | 2.3% | 
| Key | % Net Assets | 
|---|---|
| 3.0% | |
| 3.0% | |
| 2.8% | |
| 2.7% | |
| 88.5% | 
| Date | 09-Sep-2022 | 
|---|---|
| NAV | 120.80p | 
| Currency | GBP | 
| Change | 1.20p | 
| % | 1.00% | 
| YTD change | 120.80p | 
| YTD % | n/a | 
| Fund Inception | 07/02/2007 | 
|---|---|
| Fund Manager | n/a | 
| TER | 1.68 (31-Jan-2013) | 
| Minimum Investment | |
|---|---|
| Initial | £1000 | 
| Additional | £100 | 
| Savings | n/a | 
| Charges | |
|---|---|
| Initial | 4.25% | 
| Annual Mang't | 1.50% | 
| Exit | n/a | 
| Name | % | 
|---|---|
| No risk data available. | |
You are here: research